HaloPV Platform
HaloPV is the cloud native, modular, full lifecycle pharmacovigilance platform that fits any ecosystem. It automates and elevates the most complex, time-consuming processes beyond your safety system, improving compliance, efficiency, and inspection readiness.
As pharmacovigilance complexity and regulatory demands grow, teams need a more connected way to manage the processes that sit beyond the safety system. HaloPV is Qinecsa’s full-lifecycle platform, specifically built for pharmacovigilance to automate repetitive, high-effort activities with low-level disruption to existing infrastructure. It delivers flexible, modular capabilities with a proven expansion path, enabling organisations to streamline operations, reduce manual effort, and scale efficiently while strengthening compliance, visibility, and patient safety.
Schedule a HaloPV Demo
What Is HaloPV And Why It Matters
HaloPV is Qinecsa’s technology-enabled service designed to automate and elevate the most complex and business-critical pharmacovigilance processes, particularly those that sit outside core safety databases but are essential for maintaining compliance and operational control.
Unlike traditional PV systems, which focus primarily on case processing, HaloPV operates across your wider PV ecosystem to manage, coordinate, and standardize activities such as PSMF management, periodic report scheduling, authoring and coordination (including PSURs/PBRERs), local safety ICSR management, and vendor selection, agreement coordination, and ongoing oversight. It brings structure, visibility, and control to these high-risk, often fragmented processes.
This matters because many compliance gaps and inspection findings originate not within the safety database, but in the surrounding processes and governance activities. HaloPV addresses these vulnerabilities directly, helping organizations:
- Reduce manual errors and process variability
- Ensure consistent global and local PV processes
- Improve auditability, documentation, and traceability
- Strengthen oversight of vendors and partners
- Streamline reporting coordination and timelines
- Enhance inspection readiness across all PV activities
As regulatory expectations continue to evolve across EU and US frameworks, HaloPV provides a scalable, future-ready solution that enables organizations to maintain control, improve efficiency, and meet compliance obligations without increasing operational burden.
Key Features Of Our HaloPV Solution
HaloPV is designed to address the most challenging aspects of pharmacovigilance operations through a combination of automation, structure, and expert oversight.
Modular Automation
Automates repetitive, high-volume PV processes that are not effectively handled by safety databases, reducing manual workload and increasing throughput.
Structured Data Capture
Ensures consistent, high-quality data collection at the point of entry, improving downstream accuracy and regulatory compliance.
Workflow Orchestration
Coordinates activities across teams and systems, providing end-to-end visibility and control over PV processes.
Audit-Ready Documentation
Maintains clear, traceable records of all activities, supporting inspection readiness and regulatory transparency.
Scalable Operating Model
Adapts to changing volumes, product portfolios, and geographic requirements without compromising quality or control.
Integration With Existing Systems
Works alongside your safety database and broader PV ecosystem, enhancing, not disrupting, your current infrastructure.
Together, these features ensure that pharmacovigilance operations become structured, scalable, and audit-ready rather than fragmented, manual, and resource-intensive.
Bring Control And Clarity To Pharmacovigilance Operations
At Qinecsa, HaloPV is built around the real-world processes, operational pressures and regulatory responsibilities that shape pharmacovigilance beyond the safety system.
HaloPV combines modular automation, workflow orchestration and deep PV expertise to help organisations streamline the most complex and time-consuming activities across their PV landscape. Whether you need to reduce manual workload, standardise processes across regions, or improve control over fragmented workflows, HaloPV enables more efficient, scalable operations while strengthening visibility, consistency and compliance across your pharmacovigilance ecosystem.
Schedule a HaloPV Demo
How Qinecsa Delivers HaloPV
Qinecsa delivers HaloPV through a structured, consultative approach that combines process expertise, configurable technology, and operational delivery.
Process Discovery And Optimization
We begin by identifying inefficiencies, risks, and manual touchpoints across your PV processes. This ensures HaloPV is aligned to your real operational challenges, not applied as a generic solution.
Structured Automation Design
Using configurable workflows and templates, we design automation that standardizes inputs, outputs, and decision points. This structured approach ensures consistency and auditability across all activities.
Technology-Enabled Elevation
HaloPV automates activities across systems, teams, and geographies, ensuring the right tasks happen at the right time, with full visibility and control.
Operational delivery and support
HaloPV automates activities across systems, teams, and geographies, ensuring the right tasks happen at the right time, with full visibility and control.
Expert-Led Delivery
Our PV specialists remain embedded in delivery, providing oversight, governance, and continuous improvement. This ensures that automation enhances, not replaces, expert judgment.
Continuous Optimization
HaloPV evolves with your organization. We continuously refine workflows, adapt to regulatory changes, and scale capabilities as your portfolio grows.
This integrated approach ensures HaloPV delivers both immediate efficiency gains and long-term operational resilience.
How HaloPV Fits Into Your Wider PV Strategy
HaloPV is not a standalone tool, it is a strategic enabler of a modern pharmacovigilance operating model.
It complements your safety database by addressing the processes that sit around it, creating a more cohesive and controlled ecosystem.
This allows organizations to:
- Align global PV processes across affiliates and partners
- Standardize operations without losing local flexibility
- Improve data flow between systems and stakeholders
- Support scalable growth and product expansion
- Enhance overall governance and oversight
HaloPV also integrates seamlessly with other Qinecsa services, including case intake, reporting solutions, and PV consulting. This creates a unified approach to pharmacovigilance, combining technology, process, and expertise.
Qinecsa brought structure and clarity to processes we didn’t even realize were creating risk. HaloPV has transformed how we operate.
The combination of automation and expert oversight is what sets HaloPV apart. It’s not just efficient, it’s reliable and inspection ready.
Working with Qinecsa feels like an extension of our own team. They understand the detail and deliver real results.
Benefits of HaloPV With Qinecsa
Benefits for your organisation
- Strengthens global pharmacovigilance compliance across EU, US, and international frameworks
- Reduces regulatory risk through consistent, controlled processes
- Improves operational efficiency by automating repetitive tasks
- Enables scalable growth without proportional increases in resource
- Enhances inspection readiness with clear governance and audit trails
- Drives global consistency across products, affiliates, and partners
Benefits for patients and healthcare professionals
- Supports faster identification and escalation of safety issues
- Improves the quality and completeness of safety data
- Enables more timely regulatory reporting
- Strengthens overall patient safety outcomes
Benefits for internal teams
- Provides clarity through structured workflows and defined processes
- Increases confidence in data quality and compliance
- Reduces manual workload and administrative burden
- Improves cross-functional collaboration and communication
- Enables teams to focus on higher-value, expert-led activities
Why Choose HaloPV?
Organisations choose Qinecsa for Reportum because we combine specialist pharmacovigilance expertise with technology-enabled delivery.
- Deep PV Expertise
- Technology-Enabled Delivery
- Global And Local Insight
- Proven Regulatory Experience
- Integrated Solutions Portfolio
- Outcome-Focused Approach
Expert Guidance & Support
Our experts support you from initial assessment through to implementation and ongoing optimization, ensuring HaloPV is aligned to your processes and regulatory requirements. We ensure workflows are structured, efficient, and audit-ready, while continuously refining automation to maintain compliance, improve performance, and support your evolving pharmacovigilance operations.
Modules
HaloPV is a unified, full-lifecycle pharmacovigilance platform that brings together modular capabilities into a single, connected environment. Designed to automate repetitive, high-effort processes across the PV ecosystem, it enables seamless workflow orchestration, reduces manual burden, and drives operational efficiencies, while maintaining control, consistency, and compliance at every stage.
Proof in Numbers
Frequently Asked Questions About HaloPV
HaloPV is a technology-enabled service that automates and elevates pharmacovigilance processes outside the core safety database. It improves efficiency, consistency, and compliance by reducing manual activities and standardizing workflows.
HaloPV improves compliance by introducing structured workflows, standardized data capture, and full audit trails. This ensures that all activities are consistent, traceable, and aligned with global regulatory requirements.
Yes, HaloPV is designed to integrate seamlessly with existing safety databases and PV systems. It enhances your current infrastructure without requiring disruptive system changes.
HaloPV automates repetitive and manual PV processes such as intake, reconciliation, workflow management, and reporting support. These are typically areas not fully covered by traditional safety systems.
Yes, HaloPV is scalable and configurable, making it suitable for both large global organizations and smaller biotech companies. It adapts to different operating models and volumes.
HaloPV ensures inspection readiness through clear documentation, standardized processes, and complete audit trails. This provides transparency and confidence during regulatory inspections.
HaloPV focuses on the processes surrounding the safety database, rather than replacing it. Its combination of modular automation and expert-led delivery ensures both efficiency and quality.
Implementation timelines vary depending on scope, but HaloPV is designed for rapid deployment using configurable workflows. This allows organizations to see benefits quickly.
No, HaloPV enhances human expertise by reducing manual workload and enabling specialists to focus on higher-value activities. Expert oversight remains central to delivery.
HaloPV standardizes processes across regions while allowing for local regulatory requirements. This ensures global consistency with the flexibility needed for compliance.
Transform Your Pharmacovigilance Operations With HaloPV
HaloPV enables you to take control of the processes that matter most, those that sit outside your safety system but carry significant operational and compliance risk. By combining intelligent automation with deep pharmacovigilance expertise, Qinecsa helps you build a more efficient, scalable, and inspection-ready PV function.
If you are looking to reduce risk, improve efficiency, and strengthen patient safety, now is the time to rethink how your pharmacovigilance operations are delivered.
Schedule a HaloPV Demo
If your organization is looking to streamline pharmacovigilance operations, reduce manual effort, and create a more scalable, controlled operating model, HaloPV provides a more connected way to automate and orchestrate critical PV processes. See how the platform can strengthen compliance, improve workflow consistency, and help your team operate with greater efficiency and confidence.